Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Bankrupt

<< Previous

Bullboard Posts

Next >>

Comment by tylerreddickon Aug 02, 2024 4:46pm

255 Views

Post# 36161950

RE:RE:Bankrupt

Pareto8020 wrote: Looks like RBC, td and Canacord are gobbling up shares today. If this was imploding Canacord would be dumping not buying so a little bit of sunshine in an otherwise hoohum day

I'd guess the sellers know more than the buyers.
Whatever the case, it isn't just Howie who should be turfed, but the whole management.
The only people who have contributed anything useful are the lab people, everyone else is dead weight.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market